Gut bacteria capsules may stop liver-related brain fog in veterans
NCT ID NCT07528690
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether capsules containing gut microbes from healthy people can prevent future episodes of hepatic encephalopathy (a brain condition caused by liver problems) in 162 veterans with cirrhosis. Participants will take the capsules and be monitored for hospital visits or medication changes. The goal is to find a new way to stop this serious complication from coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CERC (VISN1, West Haven, CT)
West Haven, Connecticut, 06516-2770, United States
-
Richmond VA Medical Center, Richmond, VA
Richmond, Virginia, 23249-0001, United States
-
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas, 75216-7167, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Can tracking hospital care for liver patients reduce repeat admissions?
- Heart scans could uncover silent damage in liver patients awaiting transplant